Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cardiac FGF23: new insights into the role and function of FGF23 after acute myocardial infarction
David Schumacher, Setareh Alampour‐Rajabi, Victor Ponomariov, et al.
Cardiovascular Pathology (2019) Vol. 40, pp. 47-54
Closed Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

Current and novel biomarkers in cardiogenic shock
Victor Galusko, Florian A. Wenzl, Christophe Vandenbriele, et al.
European Journal of Heart Failure (2025)
Open Access | Times Cited: 2
Klotho/FGF23 and Wnt Signaling as Important Players in the Comorbidities Associated with Chronic Kidney Disease
Juan R. Muñoz‐Castañeda, Cristian Rodelo‐Haad, M. Victoria Pendón-Ruiz de Mier, et al.
Toxins (2020) Vol. 12, Iss. 3, pp. 185-185
Open Access | Times Cited: 72
An Overview of FGF-23 as a Novel Candidate Biomarker of Cardiovascular Risk
Sara Vázquez‐Sánchez, Jonay Poveda, José Alberto Navarro‐García, et al.
Frontiers in Physiology (2021) Vol. 12
Open Access | Times Cited: 53
Cardioprotective factors against myocardial infarction selected in vivo from an AAV secretome library
Giulia Ruozi, Francesca Bortolotti, Antonio Mura, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 660
Open Access | Times Cited: 34
Non-Classical Effects of FGF23: Molecular and Clinical Features
Luis Martínez-Heredia, Juan Manuel Canelo Moreno, Beatriz García-Fontana, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 9, pp. 4875-4875
Open Access | Times Cited: 4
From cancer to heart fibrosis ‐ GLIPR1 highlights a subset of myofibroblasts responsive to mesenchymal stem cell therapy after myocardial infarction
Catalina Iolanda Marinescu, Evelyn-Gabriela Nastase-Rusu, Carmen-Alexandra Neculachi, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 187, pp. 118087-118087
Closed Access
Excessive fibroblast growth factor 23 promotes renal fibrosis in mice with type 2 cardiorenal syndrome
Huixin Hao, Siyuan Ma, Cankun Zheng, et al.
Aging (2021) Vol. 13, Iss. 2, pp. 2982-3009
Open Access | Times Cited: 21
Renal fibrosis in type 2 cardiorenal syndrome: An update on mechanisms and therapeutic opportunities
Xia Xu, Bingxuan Zhang, Yajiao Wang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 164, pp. 114901-114901
Open Access | Times Cited: 8
Phosphatidylserine Supplementation as a Novel Strategy for Reducing Myocardial Infarct Size and Preventing Adverse Left Ventricular Remodeling
David Schumacher, Adelina Curaj, Mareike Staudt, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 9, pp. 4401-4401
Open Access | Times Cited: 17
Comprehensive Expression Analysis of Cardiac Fibroblast Growth Factor 23 in Health and Pressure-induced Cardiac Hypertrophy
Fiona Eitner, Beatrice Richter, Saskia Schwänen, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 9
Open Access | Times Cited: 10
Intact fibroblast growth factor 23 levels and outcome prediction in patients with acute heart failure
Anne Cornelissen, Roberta Florescu, Kinan Kneizeh, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 12
Fibroblast Growth Factor 23 Exacerbates Cardiac Fibrosis in Deoxycorticosterone Acetate-Salt Mice With Hypertension
Tomohiro Saito, Masahide Mizobuchi, Tadashi Kato, et al.
Laboratory Investigation (2023) Vol. 103, Iss. 1, pp. 100003-100003
Closed Access | Times Cited: 4
The role of nonmyocardial cells in the development of diabetic cardiomyopathy and the protective effects of FGF21: a current understanding
Tianyi Zhang, D.W. Jiang, Xiao Zhang, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 1
Novel Biomarkers of Kidney Disease in Advanced Heart Failure: Beyond GFR and Proteinuria
Bethany Roehm, Meredith McAdams, S. Susan Hedayati
Current Heart Failure Reports (2022) Vol. 19, Iss. 4, pp. 223-235
Open Access | Times Cited: 7
Biomarkers to predict improvement of left ventricular ejection fraction after atrial fibrillation ablation
Teodor Serban, Elisa Hennings, Ivo Strebel, et al.
Heart Rhythm (2024) Vol. 21, Iss. 9, pp. 1581-1588
Open Access | Times Cited: 1
miR155 Deficiency Reduces Myofibroblast Density but Fails to Improve Cardiac Function after Myocardial Infarction in Dyslipidemic Mouse Model
David Schumacher, Adelina Curaj, Sakine Simsekyilmaz, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 11, pp. 5480-5480
Open Access | Times Cited: 8
Fibroblast Growth Factor 23 and Outcome Prediction in Patients with Acute Myocardial Infarction
Anne Cornelissen, Roberta Florescu, Kinan Kneizeh, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 3, pp. 601-601
Open Access | Times Cited: 6
Short‐term fasting of mice elevates circulating fibroblast growth factor 23 (FGF23)
Martina Feger, Jana Alber, Jörg Strotmann, et al.
Acta Physiologica (2023) Vol. 239, Iss. 4
Open Access | Times Cited: 3
Exploring the implications of blocking renin-angiotensin-aldosterone system and fibroblast growth factor 23 in early left ventricular hypertrophy without chronic kidney disease
Kentaro Watanabe, Hideki Fujii, Kohei Okamoto, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 3
Cardiac FGF23: a new player in myocardial infarction
David Schumacher, Alexander Schuh
Discoveries (2019) Vol. 7, Iss. 3, pp. e97-e97
Open Access | Times Cited: 6
The relationship between Fibroblast Growth Factor 23 (FGF23) and cardiac MRI findings following primary PCI in patients with acute first time STEMI
Inga Strand Thorsen, Lasse G. Gøransson, Thor Ueland, et al.
IJC Heart & Vasculature (2021) Vol. 33, pp. 100727-100727
Open Access | Times Cited: 6
The Complexity of FGF23 Effects on Cardiomyocytes in Normal and Uremic Milieu
Andreja Figurek, Merita Rroji, Goce Spasovski
Cells (2021) Vol. 10, Iss. 5, pp. 1266-1266
Open Access | Times Cited: 6
Baseline fibroblast growth factor 23 is associated with long-term mortality in ST-elevation myocardial infarction—results from the augsburg myocardial infarction registry
Timo Schmitz, Bastian Wein, Margit Heier, et al.
Frontiers in Cardiovascular Medicine (2023) Vol. 10
Open Access | Times Cited: 2
FGF23 functions and disease
Cristiana Cipriani, Salvatore Minisola, Luciano Colangelo, et al.
Minerva Endocrinology (2021) Vol. 47, Iss. 4
Closed Access | Times Cited: 5
Pretreatment of kaempferol-3-O-rutinoside protects H9c2 cells against LPS-induced inflammation through the AMPK/SIRT1 pathway
Yao-yao Ma, Xiao-ni Zhao, Lan Zhou, et al.
Italian Journal of Food Science (2023) Vol. 35, Iss. 2, pp. 13-21
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top